Iama Therapeutics S.r.l.

This early-stage study tested a new oral drug called IAMA-6 in 72 healthy adults to see if it is safe and how the body processes it. The goal was to gather safety information, not to treat any condition. This is a first step toward possibly helping people with neurodevelopmental …